US$ 22.80
new glp 1 agonist novo nordisk Wegovy for the Treatment of Chronic Weight Management, US ๐จ JUST IN: PHASE I
Description
Kodera R, Shikata K, Kataoka HU, Takatsuka T, Miyamoto S, Sasaki M, et al

doi: 10.1038/s42255-020-00327-x 16 ZhaoXWangMWenZLuZCuiLFuCet al

Presented at the 2011 International Diabetes Federation World Diabetes congress

Online ahead of print

10.1056/NEJMoa2306963 72
doi: 10.2337/dc12-2504
